Kuros Biosciences (Formally known as Cytos Biotech; Merged with Kuros Biosurgery)
Wagistrasse 25
Postfach
Zurich-Schlieren
8952
Tel: 41-1-733-47-47
Fax: 41-1-733-47-40
Website: http://www.cytos.com/
Email: info@cytos.com
45 articles about Kuros Biosciences (Formally known as Cytos Biotech; Merged with Kuros Biosurgery)
-
Cytos Biotechnology AG Presents Additional Results From Phase 2a Study of CYT003 for the Treatment of Allergic Asthma
9/9/2013
-
Cytos Biotechnology AG Reports Second Quarter 2013 Financial Results and Recent Developments
8/6/2013
-
A*STAR and Cytos Biotechnology AG Bring Singapore's First Influenza Vaccine to Clinical Testing
5/17/2013
-
Cytos Biotechnology AG Reports First Quarter 2013 Financial Results and Recent Development
4/25/2013
-
The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study Results With Cytos Biotechnology AG’s CYT003 for the Treatment of Allergic Asthma
3/13/2013
-
Cytos Biotechnology AG VLP Platform is Basis for Phase 1 Clinical Trial with Anti-IgE Vaccine
2/4/2013
-
Cytos Biotechnology AG Reports Third Quarter 2012 Financial Results, Recent Development and Outlook
11/6/2012
-
Cytos Biotechnology AG Appoints Dr. Christian Itin as Chief Executive Officer
10/9/2012
-
Cytos Biotechnology AG Reports Second Quarter 2012 Financial Results, Recent Development and Outlook
7/30/2012
-
Cytos Biotechnology AG to Raise Up to $40 Million to Advance Phase II Asthma Immunotherapy
3/21/2012
-
Cytos Biotechnology AG Makes 80% Workforce Cut and Halts All in House Programs Except Lead Allergy Drug
8/17/2011
-
A*STAR & Cytos Biotechnology AG Establish Influenza Vaccine Collaboration
7/15/2010
-
Cytos Biotechnology AG Aiming for Lucrative Asthma Drug Deal Worth $541 Million According to CEO
6/24/2010
-
Intercell AG Acquires Antibody Technology Platform from Cytos Biotechnology AG to Further Exploit Its Capabilities to Combat Infectious Diseases; Intercell to Pay EUR 15 Million to Cytos
5/6/2010
-
Cytos Biotechnology AG Anti-Smoking Vaccine Flops
10/16/2009
-
Cytos Biotechnology AG Says Allergy Drug Meets Main Target In Study
7/31/2009
-
A*STAR Joins Forces with Swiss Company, Cytos Biotechnology AG, to Combat Hand, Foot and Mouth Disease
4/3/2009
-
Cytos Biotechnology AG Vaccine Fails Mid-stage Trial, Suspends Phase IIb Study and Plans to Reduce Workforce by 40 Percent
3/17/2009
-
Cytos Biotechnology AG Says Pfizer Inc. Takes Commercial Licenses For Some Vaccines
1/5/2009
-
Cytos Biotechnology AG Plans to Sell Rights to Hypertension Vaccine
8/20/2008